News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hydra Biosciences, Inc. Bolsters Discovery and IP Capabilities with Key Additions to Executive Management Team



10/24/2008 8:43:45 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Hydra Biosciences, a privately held biopharmaceutical company focused on developing novel drugs using its expertise in Transient Receptor Potential (TRP) ion channels, announced today the expansion of its executive management team with the appointments of David Kimball, Ph.D. as Chief Scientific Officer and Christine Bellon, Ph.D. as Vice President of IP and Legal Affairs. Dr. Kimball most recently served as Senior Vice President, Discovery, at Pharmacopeia. Dr. Bellon joins Hydra from Infinity Pharmaceuticals, where she served as Assistant General Counsel, Intellectual Property.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES